BioMarin Pharmaceuticals Inc Share Price
NASDAQ: BMRNHealthcare
Live BioMarin Pharmaceuticals Inc Share Price Chart
O H L
BioMarin Pharmaceuticals Inc Performance Overview
Days Range
▼
$64.75Low
$65.18High
Markets Today
| Previous Close | $65.08 |
|---|---|
| Open | $65.01 |
| Volume | 289,826 |
| Day's Range | $64.75 - $65.18 |
| 52W Range | $49.26 - $70.98 |
| Market Cap | $12.53 B |
Historical Performance
| 1M Returns | -2.85 |
|---|---|
| 3M Returns | +19.00 |
| 6M Returns | +17.41 |
| 1Y Returns | +18.03 |
| 5Y Returns | -16.31 |
| 10Y Returns | -33.67 |
BioMarin Pharmaceuticals Inc Fundamentals
| Market Cap | $12.53 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 174.51 |
| PEG Ratio | N/A |
| Revenue | $3.22 B |
| ROE TTM | 0.06 |
| EPS TTM | $0.37 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.98 |
| EBITDA | $489.04 M |
| Profit Margin | 10.83 |
| Market Cap | $12.53 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 174.51 |
| PEG Ratio | N/A |
| Revenue | $3.22 B |
| ROE TTM | 0.06 |
| EPS TTM | $0.37 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.98 |
| EBITDA | $489.04 M |
| Profit Margin | 10.83 |
BioMarin Pharmaceuticals Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $745.14 M | $825.41 M | $776.13 M | $874.57 M | $766.21 M | $989.71 M |
| Gross Profit + | $593.59 M | $675.32 M | $636.05 M | $598.86 M | $571.21 M | $786.91 M |
| Operating Income | $223.89 M | $281.72 M | -$46.69 M | -$44.61 M | $129.64 M | $114.20 M |
| EBITDA | $245.96 M | $300.28 M | -$28.20 M | -$24.17 M | $146.05 M | $211.84 M |
| Interest Expense | -$2.86 M | -$2.68 M | -$2.58 M | -$2.78 M | -$14.96 M | -$63.30 M |
| Depreciation | $22.07 M | $18.56 M | $18.49 M | $20.44 M | $16.41 M | $97.64 M |
| Income Before Tax | $238.09 M | $297.87 M | -$26.32 M | -$27.15 M | $141.20 M | $61.38 M |
| Income Tax Expense | $52.40 M | $57.34 M | $4.42 M | $19.42 M | $35.68 M | $16.62 M |
| Net Income + | $185.69 M | $240.53 M | -$30.74 M | -$46.57 M | $105.53 M | $44.76 M |
| Net Profit Margin | 24.92% | 29.14% | -3.96% | -5.33% | 13.77% | 4.52% |
BioMarin Pharmaceuticals Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $192.00 K | $192.00 K | $192.00 K | $192.00 K | $193.00 K | $194.00 K |
| Reserve & Surplus | $10.14 M | $186.96 M | $166.84 M | $140.73 M | $255.50 M | $295.71 M |
| Non-Current Liabilities | $725.34 M | $744.98 M | $759.72 M | $747.99 M | $1.59 B | $3.74 B |
| Current Liabilities | $628.21 M | $684.25 M | $798.44 M | $759.03 M | $793.15 M | $1.66 B |
| Total Liabilities | $1.35 B | $1.43 B | $1.56 B | $1.51 B | $2.38 B | $5.40 B |
| Fixed Assets | $1.28 B | $1.27 B | $1.27 B | $1.17 B | $1.16 B | $5.87 B |
| Current Assets | $3.47 B | $3.81 B | $3.85 B | $3.95 B | $4.61 B | $3.97 B |
| Total Assets | $7.15 B | $7.46 B | $7.61 B | $7.59 B | $8.59 B | $11.72 B |
BioMarin Pharmaceuticals Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $185.69 M | $240.53 M | -$30.74 M | -$46.57 M | $105.53 M | $44.76 M |
| Operating Cash Flow | $174.39 M | $185.27 M | $368.69 M | $99.64 M | $220.65 M | $168.11 M |
| Investing Cash Flow | -$28.24 M | -$12.59 M | -$330.96 M | -$42.45 M | $725.53 M | -$5.10 B |
| Financing Cash Flow | -$38.78 M | -$4.60 M | -$2.17 M | $3.16 M | $813.17 M | $2.74 B |
| Change in Cash | $105.96 M | $165.01 M | $36.29 M | $61.57 M | $1.76 B | -$2.20 B |
BioMarin Pharmaceuticals Inc Return Calculator
The BioMarin Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$8,371
Invested Amount$10,000
Est. Returns$-1,629
About BioMarin Pharmaceuticals Inc
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Popular Stocks
FAQs
What is the share price of BioMarin Pharmaceuticals Inc today?
BioMarin Pharmaceuticals Inc (BMRN) share price as of September 18, 2026 is $65.09. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of BioMarin Pharmaceuticals Inc?
Yes, Indian Investors can invest in the BioMarin Pharmaceuticals Inc (BMRN) Share by opening an international trading account with Angel One.
How can I purchase BioMarin Pharmaceuticals Inc shares in India?
Purchasing BioMarin Pharmaceuticals Inc (BMRN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying BioMarin Pharmaceuticals Inc (BMRN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of BioMarin Pharmaceuticals Inc?
Yes, you can purchase fractional shares of BioMarin Pharmaceuticals Inc (BMRN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of BioMarin Pharmaceuticals Inc?
The market capitalization of BioMarin Pharmaceuticals Inc on September 18, 2026, is $12.53 B.
In which sector BioMarin Pharmaceuticals Inc belongs?
BioMarin Pharmaceuticals Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in BioMarin Pharmaceuticals Inc stocks?
In order to invest in BioMarin Pharmaceuticals Inc (BMRN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
